Verified Peptides

Mazdutide Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Mazdutide

Mazdutide is studied as a dual GLP-1 receptor and glucagon receptor agonist in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin/glucagon pathway signaling, energy balance mechanisms, and glucose regulation in controlled experimental settings. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity>95-99
Categorypeptide

Latest Research

Featured Study

Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial.

Luo Y et al.Contemp Clin Trials2026

Recent research on Mazdutide: Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial.

Read Full Study on PubMed
Featured Study

Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.

Guo L et al.Nature2025

Recent research on Mazdutide: Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.

Read Full Study on PubMed

Additional Studies

Mazdutide versus placebo in Chinese adults with type 2 diabetes.

Zhu D et al.Nature2025

Recent research on Mazdutide: Mazdutide versus placebo in Chinese adults with type 2 diabetes.

Read on PubMed

Obesity in China: current progress and future prospects.

Pan XF et al.Lancet Diabetes Endocrinol2025

Recent research on Mazdutide: Obesity in China: current progress and future prospects.

Read on PubMed

Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity.

Son JW et al.Endocr Rev2025

Recent research on Mazdutide: Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity.

Read on PubMed

Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies.

Li X et al.Front Endocrinol (Lausanne)2025

Recent research on Mazdutide: Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies.

Read on PubMed

Related Research

Purchase Mazdutide from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Mazdutide - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.